A (synthetic) lethal weapon for cancer


    loading  Checking for direct PDF access through Ovid

Abstract

ROS1 inhibition in E-cadherin–deficient tumors leads to synthetic lethality, which could be exploited for the selective treatment of breast cancer patients.

    loading  Loading Related Articles